160
Participants
Start Date
September 21, 2021
Primary Completion Date
June 8, 2024
Study Completion Date
June 8, 2024
Eptinezumab
Concentrate for solution for IV infusion
DOI Clinic Internal Medicine, Hiroshima-Shi Naka-Ku
Jinnouchi Neurosurgery Clinic, Kasuga-Shi
Ikeda Neurosurgical Clinic, Kasuga-Shi
Mito Kyodo General Hospital, Mito
Iwate Medical University Uchimaru Medical Center, Morioka
Atsuchi Neurosurgery Hospital, Kagoshima
Shin Matsudakai Atago Hospital, Kochi
Sendai Headache and Cranial Nerves Clinic, Sendai-Shi Taihaku-Ku
Saitama Neuropsychiatric Institute, Saitama-Shi
Moriyama Neurological Center Hospital, Edogawa-Ku
Tokyo headache clinic, Shibuya-Ku
Nagamitsu Clinic, Hofu-Shi
Tatsuoka Neurology Clinic, Kyoto Shimojo-ku
Dokkyo Medical University Hospital, Mibu-machi
Japanese Red Cross Shizuoka Hospital, Shizuoka
Toyota Memorial Hospital, Toyota-shi
Tominaga Hospital, Osaka
H. Lundbeck A/S
INDUSTRY